The company will be delisted from the Tokyo Stock Exchange as of April 24, 2026, following the approval of a reverse stock split at the shareholders meeting on March 24, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3902","jir_company_name":"Medical Data Vision Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-04-23","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/3902-20260423-01.pdf","jir_short_summary":"The company will be delisted from the Tokyo Stock Exchange as of April 24, 2026, following the approval of a reverse stock split at the shareholders meeting on March 24, 2026.","jir_summary":"### Overview of Capital Policy\nMedical Data Vision Co., Ltd. had the proposal regarding the reverse stock split approved as originally planned at the extraordinary shareholders meeting held on March 24, 2026. Accordingly, the company\u2019s common shares meet the delisting criteria of the Tokyo Stock Exchange and will be delisted as of April 24, 2026. For further details, please refer to the press release dated March 24, 2026 titled 'Notice of Approval Resolution Regarding Reverse Stock Split, Abolishment of Unit Share System, and Partial Amendments to the Articles of Incorporation.'\n\n### Impact on Shareholders and Future Outlook\nFollowing delisting, trading of the company\u2019s shares on the Tokyo Stock Exchange will cease as of April 24, 2026. The company expresses its gratitude to shareholders for their long-standing support and pledges to continue enhancing corporate value. Specific details such as number of shares, split ratio, and capital structure remain unknown, and shareholders are advised to review the related press releases.","jir_financial_highlights":"Reverse Stock Split: Unknown (Meets delisting criteria due to reverse stock split)\nDelisting Date: 2026-04-24 (New)","jir_category":"","jir_hashtags":"#MedicalDataVision, #CapitalPolicy, #Delisting","jir_key_figures":"Delisting Date: 2026-04-24\nExtraordinary Shareholders Meeting Date: 2026-03-24\nApproval of Reverse Stock Split: Approved as originally proposed","jir_meta_title":"[Medical Data Vision] Decision on Delisting Due to Reverse Stock Split | April 2026","jir_meta_description":"Medical Data Vision Co., Ltd. approved a reverse stock split at the shareholders meeting on March 24, 2026, and will be delisted from the Tokyo Stock Exchange on April 24, 2026. Explanation of impact on shareholders and future measures.","jir_og_title":"[Medical Data Vision] Decision on Delisting Due to Reverse Stock Split | April 2026","jir_og_description":"Medical Data Vision will be delisted on April 24, 2026. The shareholders meeting approved the reverse stock split. Please refer to the press release for details.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17052,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-41794","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n